Our Mentors

All the projects selected for the programme will be assigned a mentor, a person responsible for advising on drawing up the Valorization and Business Plans and throughout the course of the programme in order to actively monitor the project and guide its evolution.

Meet our mentors

Research Director

Clara Campàs

Kern Pharma SL

Founder & CSO

Tamara Maes

Oryzon Genomics

Director

Andrés G. Fernández

Ferrer Advanced Biotherapeutics

ICREA Research Professor and Co-founder

Roger Gomis

Inbiomotion SL

Deputy Director of Innovation. Head of Health Technology Assessment Unit

Laura Sampietro

Hospital Clínic

Global Product Marketing Manager

Raúl Zurita

B. Braun España

miembro del Board

Raj Airey

SOM BIOTECH

Specialised Training

Four weeks to improve your projecte and valorisation plan

Immersion week

From July 2017

Identify what you know, what you don’t, and what you need to know; Present and contrast your original plans and receive feedback; Acquire Project Manager Role; First contact with Programme Mentors and expert groups.

Tech Transfer & Valorization week

From Septembrer 2017

Tools to improve the corresponding valorisation plan; product development (technical assessment), intellectual property legislation (IP assessment), industrial development and pitch day.

Go to Market: Licensing & Startup week

From October 2017

Basic knowledge on finance; Basic tools and practical knowledge to negotiate in the Health &Life Sciences sector; The pros and cons of licensing a product; Define your market access strategy

Financing week

From November 2017

The value of an early stage project; Investment process: from negotiating, to closing a deal; Meet relevant investors in the health and life sciences sector and obtain their feedback; Pitch day

Expert Advice

Access to an extensive directory of national and international specialists

12 hours of consultancy in various areas:
  • Drug development
  • Medical device development
  • Diagnosis development
  • Drug discovery
  • Preclinical development
  • Medicinal and compounding chemistry
  • Drug marketing
  • Medical device marketing
  • Diagnosis marketing
  • Computer-assisted tools
  • Formulation and administration
  • Prototyping and design
  • Funding
  • IP, licensing and legal issues
  • Transfer and evaluation
  • Regulatory aspects
  • Market research
  • Entrepreneurs